Jon Thorkell Einarsson
1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Impaired cellular immune responses to herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors
- Contribution to journal › Article
-
Mark
Synovial fluid potentiates local fibroblasts to drive monocyte activation in juvenile idiopathic arthritis
- Contribution to journal › Article
- 2025
-
Mark
Prevalence and Predictors of Achieving Sustained Remission in Psoriatic Arthritis : A Swedish Nationwide Registry Study
- Contribution to journal › Article
- 2024
-
Mark
Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis : what is the role of inflammation control?
- Contribution to journal › Article
-
Mark
Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis : a cohort study
- Contribution to journal › Article
-
Mark
Serologic immunogenicity and safety of herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors
- Contribution to journal › Article
-
Mark
Lifestyle discussions facilitate self-management in RA : a qualitative study of patients' perceptions
- Contribution to journal › Article
- 2021
-
Mark
Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy : A Swedish Nationwide Register Study
- Contribution to journal › Article
- 2020
-
Mark
Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden
- Contribution to journal › Article
-
Mark
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
- Contribution to journal › Article
